MU-JHU Care Ltd will participate in AIDS 2026, the 26th International AIDS Conference, taking place from 26th–31st July 2026 in Rio de Janeiro, Brazil. Representing MU-JHU Care Ltd at this year’s conference are CRS Leader Dr. Clemensia Nakabiito, Director of Research Dr. Flavia Matovu Kiweewa, Dr. Brenda Gati, Dr. Denis Kimbugwe, Dr. Grace Ahimbisibwe, Ms. Joan Nabawanika and Ms. Lydia Nakibuuka.

As part of the scientific programme, Dr. Kimbugwe will present a research poster titled, “Association Between Antepartum Maternal Inflammation and Growth Outcomes Among Children Who Are HIV-Exposed,” while Dr. Ahimbisibwe has a late breaker poster titled, “An analysis of changes in HIV-1 Proviral DNA in Women with HIV from antepartum through 48 weeks postpartum in the IMPAACT P1078 study.”

Prof. Philippa Musoke says:
“Now more than ever, as HIV programmes face unprecedented funding cuts, it is important for researchers to collaborate in shaping evidence-based HIV interventions. At MU-JHU, we are committed to being part of this effort, working with partners to ensure research continues to improve lives and strengthen the global fight against HIV.”

AIDS 2026 offers the MU-JHU team an opportunity to exchange knowledge, engage with global experts, and build partnerships that support continued progress in HIV research and public health.

The International AIDS Conference brings together researchers, policymakers, community leaders, donors, governments, persons living with HIV and health professionals to advance science, policy, and implementation efforts in the HIV response.

MU-JHU Care Ltd.’s participation highlights its commitment to producing research that informs policy and practice across HIV, tuberculosis, maternal and child health, and other public health priorities. Through collaboration and evidence generation, MU-JHU continues to contribute to improved health outcomes in Uganda and beyond.

For more information about AIDS 2026, visit: https://www.iasociety.org/conferences/aids2026